This study will look at drug levels in the blood over time and the safety of a new investigational injectable medication that combines existing short-acting oral drugs used to treat HIV. Study is approximately 2 months long. Schedule of Events: Screening Visit, Entry Visit, Visit Days: 1,...
First in human clinical trial of a next generation, long-acting injectable, combination anti-retroviral therapy platform. This study will look at drug levels in the blood over time and the safety of a single injection of a new investigational medicine that combines existing short-acting oral drugs...
The purpose of this study is to understand whether HIV medications can produce inflammation in the intestine (“your gut”) and affect the size of the HIV reservoir in people living with HIV. There are two study visits: General health assessment and medical history Endoscopy and biopsies from both...
This study is designed to help us understand how the use of a mobile app (LetSync) developed for couples can improve HIV healthcare outcomes. We are asking BIPOC couples assigned male at birth and living with HIV to use the app over the 8 month...
